New York, NY -- (SBWIRE) -- 01/28/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Atossa Genetics Inc (NASDAQ:ATOS), Progenics Pharmaceuticals, Inc (NASDAQ:PGNX), New York Mortgage Trust Inc (NASDAQ:NYMT), Oclaro, Inc (NASDAQ:OCLR)
Atossa Genetics Inc (NASDAQ:ATOS) showed a volume of 1.41 million shares by the end of last trade whereas the average volume of the stock remained 619,457 shares. The stock opened the session at $2.60 but then moved to $2.48. At that price, the stock showed a negative performance of -2.75%. Atossa Genetics Inc. is a development-stage healthcare company focused on the prevention of breast cancer through the commercialization of diagnostic tests that can detect precursors to breast cancer, and through the research, development, and ultimate commercialization of treatments for pre-cancerous lesions.
Will ATOS Get Buyers Even After The Recent Rally? Find Out Here
Progenics Pharmaceuticals, Inc (NASDAQ:PGNX) opened the session at $6.40 and closed the session at $6.45. The stock showed a positive performance of 1.26% in previous trading session. Traded with volume of 1.40 million shares in the prior session and the average volume of the stock remained 1.12 million shares. Progenics Pharmaceuticals, Inc. (Progenics) is a biopharmaceutical company focuses on research and development for biotechnology product candidates in oncology, virology, supportive care and gastroenterology.
For How Long PGNX will fight for Profitability? Read This Trend Analysis report
New York Mortgage Trust Inc (NASDAQ:NYMT) opened the session at $7.09 and closed the session at $6.92. The stock showed a negative performance of -1.70% in previous trading session. Traded with volume of 1.40 million shares in the prior session and the average volume of the stock remained 1.54 million shares. The beta of the stock remained 0.80. New York Mortgage Trust, Inc. (NYMT), together with its consolidated subsidiaries, is a self-advised real estate investment trust (REIT). The Company is engaged in acquiring and managing primarily residential adjustable-rate, hybrid adjustable-rate and fixed-rate mortgage-backed securities (RMBS),
Why Should Investors Buy NYMT After the Recent Fall? Just Go Here and Find Out
Oclaro, Inc (NASDAQ:OCLR) the stock decreased -4.18% and finished the session at $2.52. Traded with volume of 1.40 million shares in the prior session and the average volume of the stock remained 1.16 million shares. The beta of the stock remained 3.84. Oclaro, Inc. is a provider of optical communications and laser components, modules and subsystems for a range of markets, including telecommunications (telecom), industrial, scientific, consumer electronics and medical. The Company’s product offerings include tunable laser, lithium niobate external modulators, pump laser chips, thin film filters, and amplifiers.
Will OCLR Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)